Download Files:
Favipiravir
$50 – $150
Products Details
Product Description
– Favipiravir (T-705) is a potent viral RNA polymerase inhibitor, it is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5′-triphosphate (RTP). Favipiravir-RTP inhibits the influenza viral RNA-dependent RNA polymerase (RdRP) activity with an IC50 of 341 nM.
Web ID
– HY-14768
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C5H4FN3O2
References
– [1]Rocha-Pereira J, et al. Favipiravir (T-705) inhibits in vitro norovirus replication.
Biochem Biophys Res Commun. 2012 Aug 10;424(4):777-80.|[2]Furuta Y, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446-54.
CAS Number
– 259793-96-9
Molecular Weight
– 157.10
Compound Purity
– 99.97
SMILES
– O=C(N)C1=NC(F)=CNC1=O
Clinical Information
– Launched
Research Area
– Infection
Solubility
– DMSO : 100 mg/mL (ultrasonic)|H2O : 6.25 mg/mL (ultrasonic)
Target
– Bacterial;DNA/RNA Synthesis;Influenza Virus;SARS-CoV
Pathway
– Anti-infection;Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
